Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Michael Chen
Michael Chen



Jiangsu Simcere Pharmaceutical Group

陈晨 (Michael) 博士,现担任江苏先声药业副总裁,主要负责领导公司业务发展和联盟管理中国团队的工作。


归国前,陈博士先后在英国埃塞克斯大学获得细胞和分子生物学学士学位、英国诺丁汉大学获得癌症免疫治疗硕士学位、英国伦敦帝国理工大学获得生物化学博士学位。在加入默克之前,他曾在伦敦大学学院从事博士后研究,之后在英国生物技术公司 Spirogen(后被阿斯利康集团旗下全球生物制药分公司 MedImmune 收购) 领导研究项目,归国后加入药明生物和睿智化学开展商务拓展及投资工作。